Literature DB >> 8742086

Purification of single-stranded M13 DNA by cooperative triple-helix-mediated affinity capture.

A F Johnson1, R Wang, H Ji, D Chen, R A Guilfoyle, L M Smith.   

Abstract

A solid-phase triple-helix-mediated affinity capture method is described for the purification of single-stranded M13 DNA for use as template in fluorescence-based DNA sequencing reactions. In this method, a biotinylated polypyrimidine oligonucleotide "loop" bound to streptavidin-coated magnetic beads is used to selectively capture single-stranded M13 DNA from high-titer phage supernatant through the formation of a cooperative triple helix (CTH) complex between the oligonucleotide and a polypurine site previously cloned into the M13 vector. Capture is accomplished at acidic pH to encourage triple-helix formation, while elution is performed at alkaline pH with heating to destroy the CTH complex. The beads can be reused up to three times without probe replenishment. Yields of M13 ssDNA in excess of 1 microgram per milliliter of culture are obtained, sufficient for use as template in fluorescence-based DNA sequencing reactions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8742086     DOI: 10.1006/abio.1996.0053

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  3 in total

1.  Preparation of a differentially expressed, full-length cDNA expression library by RecA-mediated triple-strand formation with subtractively enriched cDNA fragments.

Authors:  T B Hakvoort; J A Spijkers; J L Vermeulen; W H Lamers
Journal:  Nucleic Acids Res       Date:  1996-09-01       Impact factor: 16.971

2.  DNA triple helix formation at oligopurine sites containing multiple contiguous pyrimidines.

Authors:  D M Gowers; K R Fox
Journal:  Nucleic Acids Res       Date:  1997-10-01       Impact factor: 16.971

Review 3.  Unraveling the structure and biological functions of RNA triple helices.

Authors:  Jessica A Brown
Journal:  Wiley Interdiscip Rev RNA       Date:  2020-05-22       Impact factor: 9.957

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.